SEC Form 4 · accession 0001209191-16-127396
Sierra Oncology, Inc. · SRRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tran Nguyen
Director
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001290149
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $2.06 | Jun 9, 2016 | A | 77,670 | A | — | Jun 9, 2026 | Common Stock | 77,670 | 77,670 | D |
Explanation of responses
- F1Stock options were granted in connection with the reporting person's appointment to the issuer's board of directors on March 18, 2016, such grant date to be effective upon the first trading day on which the issuer was not in a trading black-out period under the issuer's insider trading policy, which was June 9, 2016.
- F2The option vests as to 8.333% of the total shares monthly, beginning on July 9, 2016, with 100% of the total shares vested and exercisable on June 9, 2017, subject to the reporting person's provision of service to the issuer on each vesting date.